384 related articles for article (PubMed ID: 23341308)
81. Correlates of HPV vaccine uptake in school-based routine vaccination of preadolescent girls in Norway: A register-based study of 90,000 girls and their parents.
Hansen BT; Campbell S; Burger E; Nygård M
Prev Med; 2015 Aug; 77():4-10. PubMed ID: 25944266
[TBL] [Abstract][Full Text] [Related]
82. Evaluation of human papilloma virus (HPV) vaccination strategies and vaccination coverage in adolescent girls worldwide.
Owsianka B; Gańczak M
Przegl Epidemiol; 2015; 69(1):53-8, 151-5. PubMed ID: 25862448
[TBL] [Abstract][Full Text] [Related]
83. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.
Julius JM; Ramondeta L; Tipton KA; Lal LS; Schneider K; Smith JA
Pharmacotherapy; 2011 Mar; 31(3):280-97. PubMed ID: 21361739
[TBL] [Abstract][Full Text] [Related]
84. A qualitative descriptive study of providers' perspectives on human papillomavirus vaccine administration among Latino/a adolescents in South Texas clinics: barriers and facilitators.
Morales-Campos DY; Flores BE; Donovan E; Burdick S; Parra-Medina D; Kahn JA
BMC Public Health; 2022 Mar; 22(1):443. PubMed ID: 35248000
[TBL] [Abstract][Full Text] [Related]
85. Comparison of the implementation of human papillomavirus and hepatitis B vaccination programs in the United States: Implications for future vaccines.
Constable C; Caplan A
Vaccine; 2020 Jan; 38(5):954-962. PubMed ID: 31843271
[TBL] [Abstract][Full Text] [Related]
86. Predictors of provider recommendation for HPV vaccine among young adult men and women: findings from a cross-sectional survey.
Gerend MA; Shepherd MA; Lustria ML; Shepherd JE
Sex Transm Infect; 2016 Mar; 92(2):104-7. PubMed ID: 26297720
[TBL] [Abstract][Full Text] [Related]
87. HPV vaccination among adolescent females from Appalachia: implications for cervical cancer disparities.
Reiter PL; Katz ML; Paskett ED
Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2220-30. PubMed ID: 23136141
[TBL] [Abstract][Full Text] [Related]
88. A human rights approach to understanding provider knowledge and attitudes toward the human papillomavirus vaccine in São Paulo, Brazil.
Kruse MH; Bednarczyk RA; Evans DP
Papillomavirus Res; 2020 Jun; 9():100197. PubMed ID: 32275960
[TBL] [Abstract][Full Text] [Related]
89. Human Papillomavirus Vaccine Uptake: Increase for American Indian Adolescents, 2013-2015.
Jacobs-Wingo JL; Jim CC; Groom AV
Am J Prev Med; 2017 Aug; 53(2):162-168. PubMed ID: 28256284
[TBL] [Abstract][Full Text] [Related]
90. Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey.
Ylitalo KR; Lee H; Mehta NK
Am J Public Health; 2013 Jan; 103(1):164-9. PubMed ID: 22698055
[TBL] [Abstract][Full Text] [Related]
91. Variations in reason for intention not to vaccinate across time, region, and by race/ethnicity, NIS-Teen (2008-2016).
Hirth JM; Fuchs EL; Chang M; Fernandez ME; Berenson AB
Vaccine; 2019 Jan; 37(4):595-601. PubMed ID: 30580838
[TBL] [Abstract][Full Text] [Related]
92. Human papillomavirus vaccination related knowledge, and recommendations among healthcare providers in Southern China: a cross-sectional survey.
Chen S; Mei C; Huang W; Liu P; Wang H; Lin W; Yuan S; Wang Y
BMC Womens Health; 2022 May; 22(1):169. PubMed ID: 35568870
[TBL] [Abstract][Full Text] [Related]
93. Factors influencing Human papillomavirus (HPV) vaccination series completion in Mississippi Medicaid.
Inguva S; Barnard M; Ward LM; Yang Y; Pittman E; Banahan BF; Kirby TR; Noble SL
Vaccine; 2020 Feb; 38(8):2051-2057. PubMed ID: 31980196
[TBL] [Abstract][Full Text] [Related]
94. Promoting adolescent health through integrated human papillomavirus vaccination programs: The experience of Togo.
Engel D; Afeli ADJ; Morgan C; Zeck W; Ross DA; Vyankandondera J; Bloem P; Adjeoda KR
Vaccine; 2022 Mar; 40 Suppl 1():A100-A106. PubMed ID: 34844819
[TBL] [Abstract][Full Text] [Related]
95. Have preferences of girls changed almost 3 years after the much debated start of the HPV vaccination program in The Netherlands? A discrete choice experiment.
Hofman R; de Bekker-Grob EW; Richardus JH; de Koning HJ; van Ballegooijen M; Korfage IJ
PLoS One; 2014; 9(8):e104772. PubMed ID: 25136919
[TBL] [Abstract][Full Text] [Related]
96. Geographic variability in human papillomavirus vaccination among U.S. young women.
Wei F; Moore PC; Green AL
Am J Prev Med; 2013 Feb; 44(2):154-7. PubMed ID: 23332332
[TBL] [Abstract][Full Text] [Related]
97. Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis.
Fisher H; Trotter CL; Audrey S; MacDonald-Wallis K; Hickman M
Int J Epidemiol; 2013 Jun; 42(3):896-908. PubMed ID: 23620381
[TBL] [Abstract][Full Text] [Related]
98. Cervical cancer, human papillomavirus (HPV), and HPV vaccination: exploring gendered perspectives, knowledge, attitudes, and cultural taboos among Mexican American adults.
Morales-Campos DY; Snipes SA; Villarreal EK; Crocker LC; Guerrero A; Fernandez ME
Ethn Health; 2021 Feb; 26(2):206-224. PubMed ID: 29998738
[No Abstract] [Full Text] [Related]
99. Exploring socio-demographic and geospatial variation in human papillomavirus vaccination uptake in Virginia.
Staples JN; Nelamangala SL; Morris S; Wells K
Vaccine; 2021 Sep; 39(38):5385-5390. PubMed ID: 34384637
[TBL] [Abstract][Full Text] [Related]
100. Knowledge, Attitudes and Practices Towards Human Papillomavirus Vaccination Among Medical Doctors at a Tertiary Hospital: A Cross Sectional Study.
Lubeya MK; Zekire Nyirenda JC; Chanda Kabwe J; Mukosha M
Cancer Control; 2022; 29():10732748221132646. PubMed ID: 36214063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
